NVCR Q1 2019 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q1 2019 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$73M+40.6% YoY

Gross Profit

$53M73.0% margin

Operating Income

-$6M-8.3% margin

Net Income

-$12M-16.6% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+5.2%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$7M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$370M

Total Liabilities

$244M

Stockholders' Equity

$126M

Cash & Equivalents

$152M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$73M	$52M	+40.6%
Gross Profit	$53M	$34M	+57.9%
Operating Income	-$6M	-$13M	+51.7%
Net Income	-$12M	-$21M	+41.4%

Geographic Segments

UNITED STATES

$47M64%

E M E A

$23M31%

JAPAN

$3M5%

CHINA

$815,0001%